Rob Latta is an intellectual property transactions lawyer focusing on life sciences and environmental sustainability. He advises clients on a range of life science, agrifood, and technology transactions, including licensing, strategic alliances, joint ventures, confidentiality, manufacturing, supply, and distribution agreements. Rob's technical background coupled with extensive experience working within the life sciences allows him to bridge the gap between life sciences and computer sciences industries, particularly in matters related to computational biology and bioinformatics matters.
Rob has extensive experience negotiating complex cross-border collaboration agreements, particularly between the United States and South America, Europe, and Asia, as well as establishing multiparty international drug registries. He also assists clients with evaluating IP in due diligence and negotiates to secure optimal IP positions in connection with the acquisition or divestment of assets in the United States and abroad.
Rob has worked with leading companies in the life sciences and environmental sectors, such as Astellas, Athersys, Biomarin, Celgene, Cibus, Granite Construction, Milliken, NorthStar Group, Organon, Procter & Gamble, and Sanofi.
Rob's technical experience includes small molecule, biologics, gene editing and therapy, medical devices, data management, artificial intelligence, software, and electrical engineering.
Prior to joining Jones Day, Rob was an associate in the San Diego offices of two international law firms where he predominantly worked in patent prosecution and assisted in patent litigation and technology-based transactions. At the start of his career, he practiced intellectual property law in the Columbus, Ohio office of a national law firm.
- The Ohio State University (J.D. cum laude 2011); The University of Edinburgh, Scotland (Master of Physics with Astrophysics with honors 2007)